DNA methylation of trefoil factor 1 (TFF1) is associated with the tumorigenesis of gastric carcinoma

Molecular Medicine Reports

Volumn 9, Issue 1, 2014, Pages 109-117

  Feng, Guoxun ^a   Zhang, Yan ^b   Yuan, Huisheng ^a   Bai, Rixing ^a   Zheng, Jianwei ^a   Zhang, Jinqian ^c   Song, Maomin ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Gastric carcinoma; Trefoil factor 1; Tumorigenesis

Indexed keywords

APOPTOSIS; AZACITIDINE; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84893836846     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1772     Document Type: Article

References (49)

1. Stadtlnder CT and Waterbor JW: Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20: 2195-2208, 1999
2. Ren J, Chen Z, Juan SJ, Yong XY, Pan BR and Fan DM: Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer 88: 280-285, 2000
3. Tischoff I and Tannapfel A: DNA methylation in hepatocellular carcinoma. World J Gastroenterol 14: 1741-1748, 2008
4. Baylin SB and Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16: 168-174, 2000
5. Riggs AD and Pfeifer GP: X-chromosome inactivation and cell memory. Trends Genet 8: 169-174, 1992
6. Razin A and Cedar H: DNA methylation and genomic imprinting. Cell 77: 473-476, 1994
7. Thim L and May FE: Structure of mammalian trefoil factors and functional insights. Cell Mol Life Sci 62: 2956-2973, 2005
8. Ribieras S, Tomasetto C and Rio MC: The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim Biophys Acta 1378: F61-F77, 1998
9. Corte MD, Tamargo F, Alvarez A, Rodríguez JC, Vázquez J, Sánchez R, Lamelas ML, González LO, Allende MT, García-Muiz JL, Fueyo A and Vizoso F: Cytosolic levels of TFF1/pS2 in breast cancer: their relationship with clinical-pathological parameters and their prognostic significance. Breast Cancer Res Treat 96: 63-72, 2006.
10. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, Batzenschlager A and Chambon P: Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241: 705-708, 1988.
11. Taupin D, Pedersen J, Familari M, Cook G, Yeomans N and Giraud AS: Augmented intestinal trefoil factor (TFF3) and loss of pS2 (TFF1) expression precedes metaplastic differentiation of gastric epithelium. Lab Invest 81: 397-408, 2001.
12. Carvalho R, Kayademir T, Soares P, Canedo P, Sousa S, Oliveira C, Leistenschneider P, Seruca R, Gött P, Blin N, Carneiro F and Machado JC: Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest 82: 1319-1326, 2002.
13. Katoh M: Trefoil factors and human gastric cancer (review). Int J Mol Med 12: 3-9, 2003.
14. McChesney PA, Aiyar SE, Lee OJ, Zaika A, Moskaluk C, Li R and El-Rifai W: Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas. Cancer Res 66: 1346-1353, 2006.
15. Park WS, Oh RR, Park JY, Yoo NJ, Lee SH, Shin MS, Kim SY, Kim YS, Lee JH, Kim HS, An WG and Lee JY: Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers. Cancer Lett 159: 15-21, 2000.
16. Ribieras S, Lefèbvre O, Tomasetto C and Rio MC: Mouse Trefoil factor genes: genomic organization, sequences and methylation analyses. Gene 266: 67-75, 2001.
17. Fujimoto J, Yasui W, Tahara H, Tahara E, Kudo Y, Yokozaki H and Tahara E: DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett 149: 125-134, 2000.
18. Tomita H, Takaishi S, Menheniott TR, Yang X, Shibata W, Jin G, Betz KS, Kawakami K, Minamoto T, Tomasetto C, Rio MC, Lerkowit N, Varro A, Giraud AS and Wang TC: Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology 140: 879-891, 2011.
19. Park WS, Oh RR, Park JY, Lee JH, Shin MS, Kim HS, Lee HK, Kim YS, Kim SY, Lee SH, Yoo NJ and Lee JY: Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Gastroenterology 119: 691-698, 2000.
20. Sankpal NV, Mayo MW and Powell SM: Transcriptional repression of TFF1 in gastric epithelial cells by CCAAT/enhancer binding protein-beta. Biochim Biophys Acta 1728: 1-10, 2005.
21. Calnan DP, Westley BR, May FE, Floyd DN, Marchbank T and Playford RJ: The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS. J Pathol 188: 312-317, 1999.
22. Lefebvre O, Chenard MP, Masson R, Linares J, Dierich A, LeMeur M, Wendling C, Tomasetto C, Chambon P and Rio MC: Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262, 1996.
23. Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang J and Zhao F: The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. Exp Mol Pathol 91: 569-577, 2011.
24. Wang H, Liu H, Chen K, Xiao J, He K, Zhang J and Xiang G: SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep 28: 311-318, 2012.
25. Li L, Zhang J, Yang Y, Wang Q, Gao L, Yang Y, Chang T, Zhang X, Xiang G, Cao Y, Shi Z, Zhao M and Gao G: Single-wall carbon nanohorns inhibited activation of microglia induced by lipopolysaccharide through blocking of Sirt3. Nanoscale Res Lett 8: 100, 2013.
26. Li H, Bergeron L, Cryns V, Pasternack MS, Zhu H, Shi L, Greenberg A and Yuan J: Activation of caspase-2 in apoptosis. J Biol Chem 272: 21010-21017, 1997.
27. Fenoglio-Preisern CM, Wang J, Stemmermann GN and Noffsinger A: TP53 and gastric carcinoma: a review. Hum Mutat 21: 258-270, 2003.
28. Tahara E: Genetic pathways of two types of gastric cancer. IARC Sci Pub 157: 327-349, 2004.
29. Ballestar E and Wolffe AP: Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem 268: 1-6, 2001.
30. Babyatsky MW, deBeaumont M, Thim L and Podolsky DK: Oral trefoil peptides protect against ethanol and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497, 1996.
31. Pera M, Heppell J, Poulsom R, Teixeira FV and Williams J: Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut 48: 792-796, 2001.
32. Newton JL, Allen A, Westley BR and May FE: The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach. Gut 46: 312-320, 2000.
33. Herath NI, Leggett BA and MacDonald GA: Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol 21: 15-21, 2006.
34. Li HP, Leu YW and Chang YS: Epigenetic changes in virus-associated human cancers. Cell Res 15: 262-271, 2005.
35. Herceg Z: Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22: 91-103, 2007.
36. Adrien LR, Schlecht NF, Kawachi N, Smith RV, Brandwein-Gensler M, Massimi A, Chen S, Prystowsky MB, Childs G and Belbin TJ: Classification of DNA methylation patterns in tumor cell genomes using a CpG island microarray. Cytogenet Genome Res 114: 16-23, 2006.
37. Lund AH and van Lohuizen M: Epigenetics and cancer. Genes Dev 18: 2315-2335, 2004.
38. Sparmann A and van Lohuizen M: Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 6: 846-856, 2006.
39. Baylin SB: Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin Cancer Biol 12: 331-337, 2002.
40. Hur K, Song SH, Lee HS, Ho Kim W, Bang YJ and Yang HK: Aberrant methylation of the specific CpG island portion regulates cyclooxygenase-2 gene expression in human gastric carcinomas. Biochem Biophys Res Commun 310: 844-851, 2003.
41. Lee TL, Leung WK, Chan MW, Ng EK, Tong JH, Lo KW, Chung SC, Sung JJ and To KF: Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res 8: 1761-1766, 2002.
42. Carvalho B, Pinto M, Cirnes L, Oliveira C, Machado JC, Suriano G, Hamelin R, Carneiro F and Seruca R: Concurrent hypermethylation of gene promoters is associated with a MSH-H phenotype and diploidy in gastric carcinomas. Eur J Cancer 39: 1222-1227, 2003.
43. Byun DS, Lee MG, Chae KS, Ryu BG and Chi SG: Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 61: 7034-7038, 2001.
44. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA and Pastorino U: Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21: 3902-3908, 2003.
45. Toyota M and Issa JP: The role of DNA hypermethylation in human neoplasisa. Electrophoresis 21: 329-333, 2000.
46. Poulsen SS, Thulesen J, Christensen L, Nexo E and Thim L: Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 45: 516-522, 1999.
47. Wong WM, Poulsom R and Wright NA: Trefoil peptides. Gut 44: 890-895, 1999.
48. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG and Wright NA: Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 47: 792-800, 2000.
49. Dignass A, Lynch-Devaney K, Kindon H, Thim L and Podolsky DK: Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest 94: 376-383, 1994.